IMO, this is a RARE OPPORTUNITY like when Dendreon sold off right before the meteoric rise.
The wise see a bargain and act while the others are caught like a deer in the headlights and later say " I knew I should have"
IMO, some people are being forced to sell margin calls today because of one patient's results that we don't even know if stituvax was to blame.
Talk about an opportunity.
For less than $3.40 a share you can now get in to this stock with Merck as the partner and huge upside. If you don't know risk/reward you wouldn't be at this site. Pull the trigger on the buy. Just like those (me included) who pulled the trigger and bought DNDN before its rise.